Once-a-week pill for schizophrenia shows promise in clinical trials Updated on: July 09,2025 Once-a-week pill for schizophrenia shows promise in clinical trials Updated on:July 09,2025
C:\Users\NHHxinxi1\Desktop\每日资讯\肿瘤学与癌症_资讯\.docx Updated on: April 18,2025 C:\Users\NHHxinxi1\Desktop\每日资讯\肿瘤学与癌症_资讯\.docx Updated on:April 18,2025
Aspirin therapy proves ineffective in treating chronic rhinosinusitis with nasal polyps Updated on: September 30,2025 Aspirin therapy proves ineffective in treating chronic rhinosinusitis with nasal polyps Updated on:September 30,2025
New test identifies high-risk childhood brain tumors, improving treatment decisions Updated on: April 19,2025 New test identifies high-risk childhood brain tumors, improving treatment decisions Updated on:April 19,2025
Cancer outcomes in Australia are improving overall Updated on: November 06,2025 Cancer outcomes in Australia are improving overall Updated on:November 06,2025
Connecticut doctors are part of new cancer trials: The goal? 'Eradicate all deaths from breast cancer' Updated on: December 22,2025 Connecticut doctors are part of new cancer trials: The goal? 'Eradicate all deaths from breast cancer' Updated on:December 22,2025
Sotagliflozin outperforms dapagliflozin for reducing salt- sensitive hypertension and kidney injury in rats Updated on: December 18,2025 Sotagliflozin outperforms dapagliflozin for reducing salt- sensitive hypertension and kidney injury in rats Updated on:December 18,2025
Popular diabetes drug shows anti-aging effects among patients with type 2 diabetes Updated on: September 29,2025 Popular diabetes drug shows anti-aging effects among patients with type 2 diabetes Updated on:September 29,2025
Over half of doctors surveyed would consider assisted dying if they had advanced cancer or Alzheimer's disease Updated on: July 10,2025 Over half of doctors surveyed would consider assisted dying if they had advanced cancer or Alzheimer's disease Updated on:July 10,2025
FDA approves Romvimza for tenosynovial giant cell tumor (TGCT) Updated on: March 28,2025 FDA approves Romvimza for tenosynovial giant cell tumor (TGCT) Updated on:March 28,2025